Prescription drug · BLA
Piasky (Crovalimab) NDC 50242-115
Crovalimab 340 mg/2mL · Injection, Solution · Subcutaneous · Genentech, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50242-115-01 | 5024201150150242011501 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-115-01) / 2 mL in 1 VIAL, SINGLE-USEMarketed from Jun 20, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Piasky
- Generic name (nonproprietary)
- crovalimab
- Active ingredients
- Crovalimab — 340 mg/2mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Genentech, Inc.NDC labeler code 50242
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761388
- Marketing start
- Listing expires
- Other FDA classes
- Complement C5 Inhibitors (Mechanism)
- Identifiers
- Product ID 50242-115_04e8fab1-279a-466a-a2cf-52a0f9e550bcSPL ID 04e8fab1-279a-466a-a2cf-52a0f9e550bcSPL set ID 2597efc2-a97b-487c-b500-a67fd282a73bRxCUI 2686626, 2686633UNII H9KH1GP3UU
- Pharmacologic class
- Complement C5 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N450242011501followed by a unit qualifier and the quantityPackage 50242-0115-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
PIASKY is indicated for the treatment of adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg. PIASKY is a complement C5 inhibitor indicated for the treatment of adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 50242-115
- What is NDC 50242-115?
- 50242-115 is the product NDC for Piasky (crovalimab), Crovalimab 340 mg/2mL injection, solution, listed with the FDA by Genentech, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Piasky (Crovalimab).
- What is the active ingredient?
- Crovalimab.
- Who is the labeler?
- Genentech, Inc., NDC labeler code 50242. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Piasky?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.